Stockreport

Analysts Have Lowered Expectations For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) After Its Latest Results [Yahoo! Finance]

Zevra Therapeutics, Inc.  (ZVRA) 
PDF Results look to have been somewhat negative - revenue fell 2.2% short of analyst estimates at US$26m, although statutory losses were somewhat better. The per-share loss [Read more]